Very limited data are available, to our knowledge, on PD1 and PD-L1 expression by peripheral non lymphocytic populations in HCC and particularly in the setting of immunotherapy, where a role of innate immunity can be envisaged. Here, PDCD1 is linked to hepatocellular carcinoma.